4.6 Article

Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and MYBL2 on Ras/ErbB signaling

Related references

Note: Only part of the references are listed.
Article Oncology

Downstream Regulatory Network of MYBL2 Mediating Its Oncogenic Role in Melanoma

Feiliang Zhong et al.

Summary: MYBL2 is overexpressed in malignant and metastatic melanoma and is associated with poor prognosis. Inhibition of MYBL2 reduces cell proliferation, migration, and cell cycle progression. MYBL2 promotes the formation of melanoma stem-like cell populations and may be a potential target for treating resistant melanoma. The MYBL2 regulatory network includes core target genes such as EPPK1, PDE3A, and FCGR2A. PDE3A and EPPK1 are negatively correlated with melanoma patient survival, while FCGR2A is positively correlated.

FRONTIERS IN ONCOLOGY (2022)

Article Multidisciplinary Sciences

PIK3CB is involved in metastasis through the regulation of cell adhesion to collagen I in pancreatic cancer

Jianhua Qu et al.

Summary: This study found that PIK3CB is involved in PAAD metastasis and may serve as a potential therapeutic target for PAAD treatment. PIK3CB depletion significantly reduced PAAD metastasis potential by suppressing cell adhesion to collagen I in PAAD cells.

JOURNAL OF ADVANCED RESEARCH (2021)

Article Biochemistry & Molecular Biology

B-Myb accelerates colorectal cancer progression through reciprocal feed-forward transactivation of E2F2

Xiaoyan Fan et al.

Summary: The study revealed the critical role of B-Myb in colorectal cancer, showing its promotion of malignant phenotypes and its interaction with E2F2. They form a positive feedback loop, contributing to the progression of the tumor malignancy.

ONCOGENE (2021)

Article Cell Biology

A MYBL2 complex for RRM2 transactivation and the synthetic effect of MYBL2 knockdown with WEE1 inhibition against colorectal cancer

Qian Liu et al.

Summary: The study revealed a significant correlation between the expression of MYBL2 and RRM2 in colorectal cancer (CRC), with MYBL2 playing a crucial role in CRC cell proliferation, DNA synthesis, and cell cycle progression in an RRM2-dependent manner. MYBL2 was found to directly bind to the promoter of RRM2 gene and promote its transcription during S-phase in collaboration with TAF15 and MuvB components. Combined suppression of MYBL2 and WEE1 was shown to synergistically inhibit CRC growth with low systemic toxicity in vivo, suggesting a potential novel approach for CRC treatment targeting both transcription and degradation machinery of RRM2.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

The pro-angiogenesis effect of miR33a-5p/Ets-1/DKK1 signaling in ox-LDL induced HUVECs

Mingxue Di et al.

Summary: The study revealed that the MiR33a-5p/Ets-1/DKK1 signaling pathway is involved in ox-LDL-induced angiogenesis of HUVECs. These new findings provide a rationale and notable method for tumor therapy and cardiovascular protection.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

Article Medicine, Research & Experimental

MYBL2 disrupts the Hippo-YAP pathway and confers castration resistance and metastatic potential in prostate cancer

Qiji Li et al.

Summary: The research found that MYBL2 is significantly upregulated in CRPC tissues and cells, promoting growth and metastatic capacity. Targeting MYBL2 or using specific inhibitors can reverse resistance to ADT, block bone metastasis, and high MYBL2 levels are associated with increased risk of metastatic relapse and poor prognosis.

THERANOSTICS (2021)

Review Oncology

The Emerging Role of Ras Pathway Signaling in Pediatric Cancer

Gina M. Ney et al.

CANCER RESEARCH (2020)

Article Biochemistry & Molecular Biology

The cell cycle regulatory DREAM complex is disrupted by high expression of oncogenic B-Myb

Audra N. Iness et al.

ONCOGENE (2019)

Article Biotechnology & Applied Microbiology

Prognostic implications and oncogenic roles of MYBL2 protein expression in esophageal squamous-cell carcinoma

Hui Qin et al.

ONCOTARGETS AND THERAPY (2019)

Article Medicine, Research & Experimental

Peptide Sequence-Dependent Gene Expression of PEGylated Peptide/DNA Complexes

Mikiko Ueno et al.

MOLECULAR PHARMACEUTICS (2019)

Article Biochemistry & Molecular Biology

DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation

Sigrid Uxa et al.

NUCLEIC ACIDS RESEARCH (2019)

Article Biology

Optimized ChIP-seq method facilitates transcription factor profiling in human tumors

Abhishek A. Singh et al.

LIFE SCIENCE ALLIANCE (2019)

Article Medicine, Research & Experimental

High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma

Z. Guan et al.

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2018)

Article Oncology

MYBL2 Supports DNA Double Strand Break Repair in Hematopoietic Stem Cells

Rachel Bayley et al.

CANCER RESEARCH (2018)

Correction Biochemistry & Molecular Biology

The Human Transcription Factors (vol 172, pg 650, 2018)

Samuel A. Lambert et al.

Review Biochemistry & Molecular Biology

Class I Phosphoinositide 3-Kinase PIK3CA/p110α and PIK3CB/p110β Isoforms in Endometrial Cancer

Fatemeh Mazloumi Gavgani et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Biochemistry & Molecular Biology

GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses

Zefang Tang et al.

NUCLEIC ACIDS RESEARCH (2017)

Review Oncology

The DREAM complex: master coordinator of cell cycle-dependent gene expression

Subhashini Sadasivam et al.

NATURE REVIEWS CANCER (2013)

Article Cell Biology

The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression

Subhashini Sadasivam et al.

GENES & DEVELOPMENT (2012)